The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 424.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 14.00 (3.333%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 424.00
SAG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Science Group plc

26 Sep 2018 07:00

RNS Number : 9055B
Science Group PLC
26 September 2018
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Science Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Science Group plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

25 September 2018

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 1 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

N/A

N/A

N/A

N/A

(2) Cash-settled derivatives:

 

N/A

N/A

N/A

N/A

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

N/A

N/A

N/A

N/A

 

TOTAL:

N/A

N/A

N/A

N/A

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Ordinary Shares of 1 pence each held by directors of Science Group plc

 

 

Director

Science Group Ordinary Shares

% of Science Group issued share capital

Martin Ratcliffe

13,412,906

33.51%

David Courtley

375,000

0.94%

Rebecca Archer

60,000

0.15%

 

(b) Science Group plc 2013 Performance Share Plan granted to directors of Science Group plc

 

Director

Maximum number of ordinary shares awarded

Date of grant

Exercise price

Exercise period

Rebecca Archer

25,000

3 Sep 2015

1.0 pence

3 Sep 2018 to 3 Sep 2025

Rebecca Archer

25,000

12 Aug 2016

1.0 pence

12 Aug 2019 to 12 Aug 2026

Rebecca Archer

25,000

6 Sep 2017

1.0 pence

6 Sep 2020 to 6 Sep 2027

Rebecca Archer

100,000

14 May 2018

1.0 pence

14 May 2023 to 14 May 2028

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

26 September 2018

Contact name:

Sarah Cole,

Group Legal Counsel & Company Secretary

Telephone number:

01223 875200

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEEEALNSALFPEFF
Date   Source Headline
26th Sep 20237:00 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTransaction in Own Shares
13th Sep 20237:00 amRNSTransaction in Own Shares
12th Sep 20237:00 amRNSTransaction in Own Shares
5th Sep 20237:00 amRNSHolding(s) in Company
2nd Aug 202312:34 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSTotal Voting Rights
28th Jul 20237:00 amRNSTreasury shares issued & PDMR dealing
27th Jul 20237:00 amRNSTreasury shares issued
24th Jul 20237:00 amRNSInterim results for 6 months ended 30 June 2023
18th Jul 20231:35 pmRNSNotice of Interim Results
13th Jul 20237:00 amRNSHolding(s) in Company
12th Jun 20234:33 pmRNSHolding(s) in Company
12th Jun 20237:00 amRNSTransaction in Own Shares
18th May 202311:50 amRNSResult of AGM
18th May 20237:00 amRNSAGM Trading and Board Update
15th May 20237:00 amRNSIssue of share options & PDMR dealing
12th May 20232:05 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTransaction in Own Shares
3rd May 20237:00 amRNSTransaction in Own Shares
2nd May 20237:00 amRNSTransaction in Own Share & Total Voting Rights
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20237:00 amRNSTransaction in Own Shares
24th Apr 20237:00 amRNSTransaction in Own Shares
21st Apr 20237:00 amRNSTransaction in Own Shares
19th Apr 20237:00 amRNSTransaction in Own Shares
18th Apr 20237:00 amRNSPosting of documents and Notice of AGM
12th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 20237:00 amRNSTransaction in Own Shares
31st Mar 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20237:00 amRNSAudited Results for Year Ended 31 December 2022
16th Mar 20231:00 pmRNSNotice of Preliminary Results
14th Mar 20234:45 pmRNSHolding(s) in Company
14th Mar 20233:00 pmRNSHolding(s) in Company
13th Mar 20237:00 amRNSStatement re banking arrangements
13th Mar 20237:00 amRNSBanking Arrangements
2nd Mar 20233:06 pmRNSHolding(s) in Company
10th Feb 20231:20 pmRNSHolding(s) in Company
9th Feb 20232:45 pmRNSHolding(s) in Company
3rd Feb 20237:00 amRNSCompletion of Sale of Westek Technology Ltd
31st Jan 202312:25 pmRNSHolding(s) in Company
31st Jan 202311:35 amRNSHolding(s) in Company
26th Jan 202310:05 amRNSScheme Effective
24th Jan 20232:21 pmRNSCourt Sanction of Scheme of Arrangement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.